PROSPECTIVE EVALUATION OF HEPATIC STEATOSIS USING ULTRASOUND ATTENUATION IMAGING IN PATIENTS WITH CHRONIC LIVER DISEASE WITH MAGNETIC RESONANCE IMAGING PROTON DENSITY FAT FRACTION AS THE REFERENCE STANDARD

被引:89
作者
Jeon, Sun Kyung [1 ]
Lee, Jeong Min [1 ,2 ,3 ]
Joo, Ijin [1 ,2 ]
Yoon, Jeong Hee [1 ,2 ]
Lee, Dong Ho [1 ,2 ]
Lee, Jae Young [1 ,2 ,3 ]
Han, Joon Koo [1 ,2 ,3 ]
机构
[1] Seoul Natl Univ Hosp, Dept Radiol, 101 Daehangno, Seoul 03080, South Korea
[2] Seoul Natl Univ, Coll Med, 101 Daehangno, Seoul 03080, South Korea
[3] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea
关键词
Hepatic steatosis; Chronic liver disease; Ultrasound; Attenuation imaging; Fat quantification; Proton density fat fraction; ACOUSTIC STRUCTURE QUANTIFICATION; SHEAR-WAVE ELASTOGRAPHY; METABOLIC RISK-FACTORS; PARAMETER CAP; HEPATOCELLULAR-CARCINOMA; FIBROSIS; REPRODUCIBILITY; RELIABILITY; DIAGNOSIS; HISTOLOGY;
D O I
10.1016/j.ultrasmedbio.2019.02.008
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
The purpose of our study was to investigate the diagnostic performance of 2-D ultrasound attenuation imaging (ATI) for the assessment of hepatic steatosis in patients with chronic liver disease using magnetic resonance imaging proton density fat fraction (MRI-PDFF) as the reference standard. We prospectively analyzed 87 patients with chronic liver disease who had reliable measurements at both ATI and MRI-PDFF. For the detection of hepatic steatosis of MRI-PDFF >= 5% and MRI-PDFF >= 10%, ATI measurements yielded areas under the receiver operating characteristic curve of 0.76 and 0.88, respectively (95% confidence intervals: 0.66-0.85 and 0.79-0.94). Attenuation coefficients at ATI were moderately correlated with MRI-PDFF (rho = 0.66). In conclusion, attenuation coefficients at ultrasound ATI were well correlated with MRI-PDFF and, thus, may provide good diagnostic performance in the assessment of hepatic steatosis, making these coefficients a promising tool for the non-invasive assessment and quantification of hepatic steatosis. (E-mail: jmsh@snu.ac.kr) (C) 2019 World Federation for Ultrasound in Medicine & Biology. All rights reserved.
引用
收藏
页码:1407 / 1416
页数:10
相关论文
共 52 条
[1]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]   Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease: Controlled attenuation parameter for steatosis [J].
Berzigotti, Annalisa .
JOURNAL OF HEPATOLOGY, 2014, 60 (05) :910-912
[3]   The burden of liver disease in Europe: A review of available epidemiological data [J].
Blachier, Martin ;
Leleu, Henri ;
Peck-Radosavljevic, Markus ;
Valla, Dominique-Charles ;
Roudot-Thoraval, Francoise .
JOURNAL OF HEPATOLOGY, 2013, 58 (03) :593-608
[4]   Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis [J].
Caussy, Cyrielle ;
Alquiraish, Mosab H. ;
Nguyen, Phirum ;
Hernandez, Carolyn ;
Cepin, Sandra ;
Fortney, Lynda E. ;
Ajmera, Veeral ;
Bettencourt, Ricki ;
Collier, Summer ;
Hooker, Jonathan ;
Sy, Ethan ;
Rizo, Emily ;
Richards, Lisa ;
Sirlin, Claude B. ;
Loomba, Rohit .
HEPATOLOGY, 2018, 67 (04) :1348-1359
[5]   Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population [J].
Chon, Young Eun ;
Jung, Kyu Sik ;
Kim, Seung Up ;
Park, Jun Yong ;
Park, Young Nyun ;
Kim, Do Young ;
Ahn, Sang Hoon ;
Chon, Chae Yoon ;
Lee, Hye Won ;
Park, Yehyun ;
Han, Kwang-Hyub .
LIVER INTERNATIONAL, 2014, 34 (01) :102-109
[6]   Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study [J].
Dasarathy, Srinivasan ;
Dasarathy, Jaividhya ;
Khiyami, Amer ;
Joseph, Rajesh ;
Lopez, Rocio ;
McCullough, Arthur J. .
JOURNAL OF HEPATOLOGY, 2009, 51 (06) :1061-1067
[7]   EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease [J].
European Association for the Study of the Liver .
DIABETOLOGIA, 2016, 59 (06) :1121-1140
[8]   Diabetes Mellitus Is Associated with Impaired Response to Antiviral Therapy in Chronic Hepatitis C Infection [J].
Elgouhari, Hesham M. ;
Zein, Claudia O. ;
Hanouneh, Ibrahim ;
Feldstein, Ariel E. ;
Zein, Nizar N. .
DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (12) :2699-2705
[9]   Steatosis and hepatitis C [J].
Esfeh, Jamak Modaresi ;
Ansari-Gilani, Kianoush .
GASTROENTEROLOGY REPORT, 2016, 4 (01) :24-29
[10]   Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature [J].
Fabiani, Silvia ;
Fallahi, Poupak ;
Ferrari, Silvia Martina ;
Miccoli, Mario ;
Antonelli, Alessandro .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2018, 19 (04) :405-420